C3 IoT, the leading AI and IoT software platform provider for digital transformation, announced a new round of financing by existing investors TPG Growth, Breyer Capital, Sutter Hill, Pat House and Thomas M. Siebel. Joining the round is The Rise Fund, the global investment fund that is committed to achieving measurable social and environmental outcomes alongside competitive financial returns. C3 IoT provides several AI-based product offerings that deliver environmental and social benefits, such as energy management and precision health solutions.
Connected2Fiber, provider of the leading SaaS platform used by B2B connectivity providers to manage and transform market data, announced that it has closed $8 million in additional funding from Ascent Venture Partners, Nauta Capital, NXT Ventures and Osage Venture Partners. The Series A round follows a period of sustained and rapid growth for Connected2Fiber over the past two years, as location management and marketing has increasingly become a must-have for modern marketers in the connectivity industry.
Pony.ai, a company that builds autonomous driving solutions, has closed a funding round of $112M. The Series A round was co-led by Morningside Venture Capital and Legend Capital. Seed round lead-investor Sequoia China and investor IDG Capital also participated in the round, along with Hongtai Capital, Legend Star, Puhua Capital, Polaris Capital, DCM Ventures, Comcast Ventures, Silicon Valley Future Capital and other funding sources. Miracle Capital was the exclusive financial advisor in this round.
True Fit, the retail industry’s data-driven personalization platform for apparel and footwear today announced a new $55 million Series C investment, led by Georgian Partners with participation from existing investors Jump Capital, Signal Peak Ventures, Intel Capital, and new investor Cross Creek Capital.
Harver, the leading software in AI pre-hiring and talent-matching, announced it has raised an additional $4.2 million USD in growth round as part of a Series A funding led by Insight Venture Partners. This brings Harver’s total funding to $15.6 million USD.
minuteKEY, the world’s first and largest network of self-service kiosks for accurate key duplication, announced that it has closed an $83 million capital raise, which was arranged by Lincoln International. Funds from the transaction will support minuteKEY’s impressive record of growth, as its latest generation of automated key duplication kiosks continues to roll out to retailers across the United States and Canada.
Outside Financial, LLC, a financial technology company focused on improving the auto financing experience, raised $1.5M to launch its innovative, consumer-first platform.
FieldIn, an Israeli Startup That is Disrupting AgPest Via IoT & Big Data, Completes a $4M Funding Round: FieldIn is disrupting the $65 Billion Agricultural Pesticide (AgPest) market utilizing IoT devices connected to its powerful analytics platform, providing growers with unprecedented control over their farming operations, while constructing the largest AgPest dataset in existence. Over the past two years FieldIn has successfully monitored over 1 million sprayed acres in real-time, to discover that more than 25% of sprays were performed with consequential errors. Moreover, according to publications, over $300B of annual world crops is lost due to problems related to pest and disease control. FieldIn’s innovative technology allows growers, as well as the entire AgPest supply chain (from growers to retailers), to improve yields, decrease costs and dramatically reduce the impact of pesticides on our entire environment.
Reviver Auto, creator of the RPlate™, the world’s first digital license plate, has closed an $11.1 million funding round led by Australian-based ACK Group, with participation from WRV and a number of strategic individual investors.
ClearLine MD, a medical device company focused on reducing the impact of iatrogenic Air Burden to patients and improving the safety and effectiveness of intravenous (IV) therapy, announced the closing of its latest funding round of $5.5 million.
STORM Therapeutics, the leading drug discovery company focused on small molecule therapies modulating RNA modifying enzymes, announced that it has raised an additional £4 million of funding from Taiho Ventures, LLC the strategic corporate venture capital arm of Taiho Pharmaceutical Co., Ltd. This is an addition to the £12 million Series A Financing announced in June 2016. Taiho Ventures joins the existing blue chip investor syndicate of Merck Ventures, Cambridge Innovation Capital, Pfizer Venture Investments and Touchstone Innovations with an equal size of investment. Sakae Asanuma, President of Taiho Ventures, joins STORM Therapeutics’ Board of Directors.
Alveo Technologies, Inc., whose mission it is to create affordable and accessible infectious disease diagnostic devices, announced the closing of a $38 million Series A financing raised by Maxim Merchant Capital, a division of Maxim Group LLC. The round was oversubscribed and included existing and new investors. The offering proceeds will be used to advance the optimization and commercialization of Alveo’s rapid diagnostic platform for infectious diseases.
Radisys Corporation (NASDAQ: RSYS), a global leader of open telecom solutions, today announced the Company closed a $17 million financing with Hale Capital Partners (“HCP”) and also entered into a newly established $20 million asset-backed line of credit agreement with Marquette Business Credit, a subsidiary of UMB Bank. In conjunction with securing the new financing, the Company settled all outstanding balances and terminated its previous line of credit with Silicon Valley Bank.
ENTEROME SA, a clinical-stage biotech company pioneering innovative therapies to treat microbiome-associated diseases with a focus on inflammatory bowel diseases (IBD) and immuno-oncology (IO) indications, announces that it has raised €32 million in a Series D financing. All current Enterome investors – Seventure, Health for Life Capital, LundbeckFonden Ventures, Omnes Capital and Nestlé Health Science – participated in the round, alongside new venture investor Principia SGR and strategic investor Bristol-Myers Squibb.
Oculis (www.oculis.com), a clinical-stage biotechnology company focused on the development of breakthrough non-invasive topical treatment for back-of-the-eye diseases, announced it has successfully closed a Series B financing round of CHF 20 million (USD 20.3 million). The financing was led by a syndicate of leading international life science investors including Bay City Capital, Novartis Venture Fund and Pivotal bioVenture Partners. Existing investors, including Brunnur Ventures and Silfurberg, also participated in the financing.
Themis announced the close of a Series C financing round totaling EUR 10 million. Global Health Investment Fund (GHIF), a New York-based impact investment firm focused on medical innovations for major public health challenges, led the financing as a new investor in the company, together with a number of current investors, including aws Gruenderfonds, Omnes Capital, Ventech and Wellington Partners Life Sciences. Glenn Rockman, Partner at GHIF, will join Themis’ Supervisory Board. The Series C proceeds will be used to advance Themis’ clinical and pre-clinical vaccine development programs, including its most advanced vaccine against chikungunya virus, on which the company recently reported positive Phase 2 results
AImotive, the full-stack autonomous vehicle technology company, announced the closing of its $38 million USD/ €32 million Series C funding round, led by B Capital Group and Prime Ventures, with participation from Cisco Investments, Samsung Catalyst Fund, and Series A and B investors Robert Bosch Venture Capital, Inventure, Draper Associates and Day One Capital.
SomaLogic announced that it has capped its $200 million funding round, anchored by iCarbonX with substantial investments from Nan Fung Life Sciences and Madryn Asset Management. The successful round will accelerate SomaLogic’s goal of becoming the world’s leading provider of precision digital health insights.
Recros Medica, Inc., a development stage medical aesthetic device company focused on reducing skin laxity and focal contouring, announced that it has closed a $9M financing. Additionally, the company is strengthening its Board of Directors with the additions of Christoph Westphal, MD, PhD and Mark Kerslake.
Concord, a leading contract management platform, announced the closing of $10 million Series A funding. The round was led by CRV (Charles River Ventures) and joined by Alven Capital who led Concord’s seed round. The funding will be used to scale the product and commercial teams during this hyper-growth phase.
BondLink, a Boston, Mass.-based provider of software to issuers in the roughly $4 trillion municipal bond market, announced a $10 million financing round led by Franklin Templeton Investments, one of the largest municipal bond fund managers in the country.